DUBLIN–(BUSINESS WIRE)–The “Bioinformatics – Market Insights, Competitive Landscape and Market Forecast-2027” report has been added to ResearchAndMarkets.com’s offering.
The global bioinformatics market was valued at USD 20.12 Billion in 2021, growing at a CAGR of 15.14% during the forecast period from 2022 to 2027 to reach USD 46.88 Billion by 2027.
Companies Mentioned
- Agilent Technologies
- Biomax Informatics AG
- DNANEXUS, INC.
- Thermo Fisher Scientific, Inc
- Eurofins Scientific
- QIAGEN N.V.
- Illumina Inc.
- NeoGenomics Laboratories
- Rosalind Inc.
- Perkin Elmer, Inc.
- GENEWIZ
- BGI Corporation
- Waters Corporation
- DNASTAR
- Fios Genomics
- Partek Incorporated
- SOPHiA Genetics
- Source Bioscience
- Biomax Informatics AG
- Seven Bridges Genomics Inc
The Bioinformatics market is witnessing positive growth owing to the rising demand for both nucleic acid and protein sequencing, rising need for integrated data, technological innovation in product development, thereby contributing to the growth of the Bioinformatics market during the forecast period from 2022-2027.
Bioinformatics Market Dynamics:
The Bioinformatics market is witnessing a growth in product demand owing to various reasons. The rising demand for both nucleic acid and protein sequencing is the key driving factor for the Bioinformatics market.
Protein sequencing is the practical process of determining the amino acid sequence of all or parts of a protein or peptide. Protein sequencing is the process that helps in the identification of protein or characterizing the post-translational modifications.
DNA sequencing is the process for determining the nucleic acid sequence-the order of nucleotides in the DNA. It includes different methods or technology for determining the order of the four bases, such as adenine, guanine, cytosine, and thymine.
The introduction of various tools such as DNAnexus Apollo and DNAnexus Titan by DNANEXUS INC. helps in accelerating the process of precision drug discovery.
Furthermore, the bioinformatics platform also provides precision drug discovery programs by empowering the scientists and clinicians for exploring and analyzing both omics and clinical data together, in a single environment based on a robust, scalable, cloud platform. These platforms will further contribute to the industry’s growth.
Furthermore, the need for disease management, prevention, and treatment coupled with developments in bioinformatics augments the market growth.
Most importantly, the current COVID-19 pandemic and demand for newer treatments and vaccines will also increase the demand for nucleic acid and protein sequencing.
Therefore, due to the rising demand for nucleic acid and protein sequencing, there will be an increase in the demand for bioinformatics, thereby fueling the market growth for Bioinformatics.
However, higher costs associated with the bioinformatics software and services and dearth of skilled professionals may be certain limiting factors of the Bioinformatics market growth.
The unprecedented COVID-19 outbreak had a profound impact on the market for Bioinformatics. Most importantly, the current COVID-19 pandemic and the rising demand for newer treatments and vaccines help in providing better opportunities for the global bioinformatics market. Bioinformatics has always had huge potential when it comes to providing essential support to several areas of scientific research. One of the major focus areas for every country during COVID-19 has been to study and halt the progress of the virus.
Recent Developmental Activities in the Bioinformatics Market:
- On March 02, 2022, BISC Global, a Bioinformatics, Biostatistics, and ML/AI consulting company is partnering with cropSeq bioinformatics, a company specialized in AgriGenomics consulting, to address the most pressing challenges in data-driven agriculture and plant research.
- In February 2022, Bruker Corporation announced its TIMS DIA-NN software for the high-throughput, deep and unbiased 4D proteomics workflow.
Key Takeaways from the Bioinformatics Market Report Study
- Market size analysis for current Bioinformatics market size (2020), and market forecast for 5 years (2022-2027).
- The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the Bioinformatics market.
- Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years.
- Key companies dominating the global Bioinformatics market.
- Various opportunities available for the other competitor in the Bioinformatics market space.
- What are the top-performing segments in 2021? How these segments will perform in 2026.
- Which is the top-performing regions and countries in the current Bioinformatics market scenario?
- Which are the regions and countries where companies should have concentrated on opportunities for Bioinformatics market growth in the coming future?
Key Topics Covered:
1. Bioinformatics Market Report Introduction
2. Bioinformatics Market Executive Summary
2.1. Scope of the Study
2.2. Market at Glance
2.3. Competitive Assessment
3. Regulatory Analysis
3.1. The United States
3.2. Europe
3.3. Japan
3.4. China
4. Bioinformatics Market Key Factors Analysis
4.1. Bioinformatics Market Drivers
4.1.1. Rising Demand For Both Nucleic Acid and Protein Sequencing
4.1.2. Rising Need For Integrated Data
4.1.3. Technological Innovation in Product Development
4.2. Bioinformatics Market Restraints and Challenges
4.2.1. Higher Costs Associated with the Bioinformatics Software and Services
4.2.2. Dearth of Skilled Professionals
4.3. Bioinformatics Market Opportunities
4.3.1. Growing Popularity of Bioinformatics in Different Application Areas such as Personalized Medicine
4.3.2. Growing Pharmaceutical and Biotechnology Research & Development Expenditure
5. Bioinformatics Market Porter’s Five Forces Analysis
6. COVID-19 Impact Analysis on Bioinformatics Market
7. Bioinformatics Market Layout
7.1. By Type
7.2. By Bioinformatics Products
7.3. By Application
7.4. By Sector
7.5. By Geography
8. Bioinformatics Market Company and Product Profiles
9. KOL Views
10. Project Approach
11. About the Publisher
12. Disclaimer & Contact the Publisher
For more information about this report visit https://www.researchandmarkets.com/r/jk646m
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
